Physician profile
Robert Nudelman
NPI 1750476891
$1,736.50
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $538 · 2020: $289 · 2021: $437 · 2022: $44.51 · 2023: $239 · 2024: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $427.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $251.48 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $245.41 | 2019-2024 | Vaxelis, Gardasil 9, M-M-R II |
| Takeda Pharmaceuticals U.S.A., INC. | $236.48 | 2019-2021 | |
| Glaxosmithkline, LLC. | $158.94 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $156.17 | 2021 | |
| Adlon Therapeutics L.P. | $137.99 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $83.30 | 2019 | |
| Jazz Pharmaceuticals INC. | $78.01 | 2019 | |
| Kaleo, INC. | $62.19 | 2019-2023 | Auvi-Q |
| Sanofi Pasteur INC. | $56.28 | 2023 | |
| Cranial Technologies, INC | $50.65 | 2019-2024 | Doc Band |
| Verrica Pharmaceuticals INC. | $47.83 | 2024 | Ycanth |
| Seqirus USA INC | $27.49 | 2023 | Flucelvax Quadrivalent |
| Novo Nordisk INC | $25.69 | 2019 | |
| Alk-Abello, INC | $23.99 | 2023 | Grastek, Odactra, Ragwitek |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $23.53 | 2024 | |
| Arbor Pharmaceuticals, INC. | $20.97 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $18.07 | 2019 | |
| Tris Pharma INC | $17.24 | 2021 | |
| Shire North American Group INC | $14.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Nudelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.